Strategic Research Institute Release: Meeting The R&D Innovation Challenge: New Technologies And New Pipeline Strategies Highlight Next Week's Rx & Biotech Portfolio Management Conference
2/8/2007 11:37:05 AM
SAN FRANCISCO--(BUSINESS WIRE)--Recent developments in biopharmaceutical R&D indicate that blockbuster drugs alone will not be sufficient to drive revenue growth. With big pharma discovering fewer and fewer new medicines in their own labs and major product failures occurring in late stage development, large companies have been pushed to search for more innovative strategies for growing and managing a sustainable pipeline.
comments powered by